Allos
Allos is an AI-powered platform that applies Causal AI and scientific models to improve drug discovery, enabling insights and treatments.
Funding
Every round, secondary, debt facility or acquisition involving Allos that Lounge tracks, newest first.
No rounds recorded yet.
Timeline · 1
In the news
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $37/mo.
See plans →Log in